JENNIFER PATTIE: Open Payments
NPI 1457754855 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 13 payments from 9 companies in 2025. Trend: 2023 $791 · 2024 $690 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Lilly USA, LLC | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Stryker Corporation | 1 | $15 |
Products named: Dyanavel XR, XIFAXAN, MOUNJARO, ROTATEQ, FREESTYLE LIBRE 3, TRINTELLIX, Veozah, Ozempic.
Industry payments across MS — which companies pay providers there.
